Science Explorer Interactive view Map
Company · Princeton · United States

Taiho Oncology (United States)

taihooncology.com/usROR OpenAlex
Research works
64
▲ 211% vs 2013–17
Citations
948
14.7 per fractional work
Top-10% rate
12.3%
record average 16.5%
Open access
30%
world 28%

Not ranked overall: Taiho Oncology (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.48× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 0.98× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 4.60× its world share, 0 worksPharmacology, Toxico…Computer Science: 0.08× its world share, 0 worksComputer ScienceEngineering: 0.01× its world share, 0 worksEngineeringMathematics: 0.57× its world share, 0 worksMathematicsMedicine: 3.74× its world share, 15 worksMedicineEconomics, Econometrics and Finance: 2.29× its world share, 1 worksEconomics, Econometr…Social Sciences: 0.05× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 4.6×. Every wedge is a field page.

Who are the top researchers at Taiho Oncology (United States)?

Ranked on the composite score, Lukas Makris lead among researchers whose main affiliation is Taiho Oncology (United States).

  1. 1 Lukas Makris United States · #1,049,397 worldwide 11 citations · 15 works
All ranked researchers at Taiho Oncology (United States)

Which keywords describe research at Taiho Oncology (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Prognostic Factors, Chemotherapy, Acute Myeloid Leukemia, AML, Cancer, Metabolism, Signaling and Obesity.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 20 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Prognostic Factors5▲ 52×7 topics
  2. Chemotherapy3▲ 23×10 topics
  3. AML2▲ 205×1 topic
  4. Acute Myeloid Leukemia2▲ 205×1 topic
  5. Cancer2▲ 7.6×5 topics
  6. Metabolism2▲ 19×2 topics
  7. Signaling2▲ 173×2 topics
  8. Obesity2▲ 12×2 topics
  9. Epidemiology2▲ 2.2×6 topics
  10. FGF212▲ 749×1 topic
  11. Fibroblast Growth Factor2▲ 749×1 topic
  12. Cetuximab2▲ 96×1 topic
  13. KRAS Mutations2▲ 248×1 topic
  14. Molecular Characterization1▲ 33×4 topics
  15. Surgical Management1▲ 13×2 topics
  16. Biliary Tract Cancer1▲ 137×1 topic
  17. Cholangiocarcinoma1▲ 64×1 topic
  18. Mutation1▲ 26×2 topics
  19. Rituximab1▲ 33×2 topics
  20. Targeted Therapy1▲ 22×2 topics

Which research topics does Taiho Oncology (United States) publish most on?

By volume in 2022–2025: Acute Myeloid Leukemia Research, Fibroblast Growth Factor Research, Colorectal Cancer Treatments and Studies and Cholangiocarcinoma and Gallbladder Cancer Studies.

Acute Myeloid Leukemia Research: 2 fractional worksFibroblast Growth Factor Research: 2 fractional worksColorectal Cancer Treatments and Studies: 2 fractional worksCholangiocarcinoma and Gallbladder Cancer Studies: 1 fractional worksChronic Myeloid Leukemia Treatments: 1 fractional worksGastric Cancer Managemen…1Gastric Cancer Management and Outcomes: 1 fractional worksLung Cancer Treatments and Mutations: 1 fractional worksCancer Treatment and Pharmacology: 1 fractional worksEconomic and Financial Impacts of Cancer: 1 fractional worksChronic Lymphocytic Leukemia Research: 1 fractional works
HematologyMolecular BiologyOncologySurgery3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Acute Myeloid Leukemia Research Hematology 2 works
  2. 2 Fibroblast Growth Factor Research Molecular Biology 2 works
  3. 3 Colorectal Cancer Treatments and Studies Oncology 2 works
  4. 4 Cholangiocarcinoma and Gallbladder Cancer Studies Surgery 1 works
  5. 5 Chronic Myeloid Leukemia Treatments Hematology 1 works
  6. 6 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 1 works
  7. 7 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
  8. 8 Cancer Treatment and Pharmacology Oncology 1 works
  9. 9 Economic and Financial Impacts of Cancer Economics and Econometrics 1 works
  10. 10 Chronic Lymphocytic Leukemia Research Genetics 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available30.2%not open69.8%

World: 28% of research is openly available.

with international co-authors38.1%domestic only61.9%

World: 19% is written across borders.

How has Taiho Oncology (United States)'s research output changed?

Output in 2018–2022 was 211% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Princeton

All research institutions in Princeton

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.